Monday, April 28, 2014

Video - Pricey Hepatitis C Pill Sovaldi Rattles Medicaid Programs

Pricey Hepatitis Pill Sovaldi Rattles Medicaid Programs
April 28th, 2014 by ABMN Staff

Medicaid health insurance programs for the poor are grappling with how to pay for the costly Hepatitis C treatment Sovaldi, which costs $1,000 a pill and is running up a huge tab for states already grappling with myriad health and general budgetary issues. The costs are hitting Medicaid programs extraordinarily hard because the population of patients in need of Sovaldi tend to have low incomes and wouldn’t be able to afford it without the government insurance.

“Pricey Hepatitis Pill Sovaldi Rattles Medicaid Programs” is categorized as “world”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.


  1. What is this cost compared to the cost of failure? How many unsuccessful HCV treatments has Medicaid paid for so far? How much has been paid for liver transplants? Hospitalizations due to HCV? Liver failure? Surely, the cost of an effective CURE is less than the cost of multiple failures, especially related to Interferon based failures where side effects are significant.

  2. HCV is very costly, when end stage sets in.